Post-Vaccination Neutralization Responses to Omicron Sub-Variants

Post-Vaccination Neutralization Responses to Omicron Sub-Variants

Background: The emergence of the Omicron variant (B.1.1.529), which correlated with dramatic losses in cross-neutralization capacity of post-vaccination sera, raised concerns about the effectiveness of COVID-19 vaccines against infection and disease. Several clinically relevant sub-variants subseque...

Full description

Bibliographic Details
Main Authors:	Henning Jacobsen, Maeva Katzmarzyk, Melissa M. Higdon, Viviana Cobos Jiménez, Ioannis Sitaras, Naor Bar-Zeev, Maria Deloria Knoll
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Vaccines
Subjects:	SARS-CoV-2 Omicron sub-variant neutralization COVID-19 vaccine
Online Access:	https://www.mdpi.com/2076-393X/10/10/1757

Similar Items

Post-vaccination T cell immunity to omicron
by: Henning Jacobsen, et al.
Published: (2022-07-01)

Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
by: Ioannis Sitaras, et al.
Published: (2022-11-01)

Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2
by: Henning Jacobsen, et al.
Published: (2023-10-01)

Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera
by: Henning Jacobsen, et al.
Published: (2022-05-01)

Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant
by: Xiaoling Yu, et al.
Published: (2022-02-01)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
by: Jinkai Zang, et al.
Published: (2022-06-01)

Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
by: Alina Seidel, et al.
Published: (2023-03-01)

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
by: Hancong Sun, et al.
Published: (2022-06-01)

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice
by: Jianyang Liu, et al.
Published: (2023-12-01)

Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
by: Maeva Katzmarzyk, et al.
Published: (2023-11-01)

Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage
by: Jidapa Szekely, et al.
Published: (2023-07-01)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
by: Ruoke Wang, et al.
Published: (2022-06-01)

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
by: Ju-yeon Choi, et al.
Published: (2022-07-01)

The Difference in Wave Dynamics between SARS-CoV-2 Pre-Omicron and Omicron Variant Waves
by: Franz Konstantin Fuss, et al.
Published: (2022-12-01)

Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron
by: Linhui Hao, et al.
Published: (2023-02-01)

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
by: Ailan Xu, et al.
Published: (2022-09-01)

The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
by: Prerna Arora, et al.
Published: (2022-11-01)

Levels and durability of neutralizing antibodies against SARS-CoV-2 Omicron and other variants after ChAdOx-1 or BNT162b2 booster in CoronaVac-primed elderly individuals
by: Nuchjira Takheaw, et al.
Published: (2023-04-01)

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic
by: Dani Cohen, et al.
Published: (2023-07-01)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
by: Shohei Yamamoto, et al.
Published: (2023-05-01)

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
by: Chengbao Ma, et al.
Published: (2022-12-01)

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH
by: Alessandra Vergori, et al.
Published: (2022-08-01)

Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
by: Jingwen Ai, et al.
Published: (2022-12-01)

Omicron sub-variants: is the world going to witness another wave?
by: Amit Aggarwal, et al.
Published: (2022-06-01)

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
by: Daniele Lapa, et al.
Published: (2022-05-01)

Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants
by: Yudi Xie, et al.
Published: (2022-09-01)

Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines
by: Lu Lu, et al.
Published: (2022-05-01)

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
by: Chaitanya Kurhade, et al.
Published: (2022-12-01)

A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab
by: Margherita Passariello, et al.
Published: (2022-05-01)

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
by: David Niklas Springer, et al.
Published: (2023-07-01)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01)

Intramuscular injection of a mixture of COVID-19 peptide vaccine and tetanus vaccine in horse induced neutralizing antibodies against authentic virus of SARS-CoV-2 Delta variant
by: Weiwen Deng, et al.
Published: (2022-12-01)

Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection
by: Aidibai Simayi, et al.
Published: (2023-01-01)

Long-term analysis of humoral responses and spike-specific T cell memory to Omicron variants after different COVID-19 vaccine regimens
by: Chia-Lo Ho, et al.
Published: (2024-03-01)

Comparison of the replication and neutralization of different SARS‐CoV‐2 Omicron subvariants in vitro
by: Yaqing Zhang, et al.
Published: (2023-02-01)

Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis
by: Kaiming Tao, et al.
Published: (2022-08-01)

The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population
by: Jéssica Pires Farias, et al.
Published: (2023-12-01)

Heterogeneity of the Omicron variant in Senegal
by: Cyrille Kouligueul Diédhiou, et al.
Published: (2022-04-01)

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
by: Ka-Wa Khong, et al.
Published: (2022-01-01)

Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
by: Kristin Widyasari, et al.
Published: (2023-08-01)